Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,865 | -1,436 | 513 | 1,248 | -6,444 |
| Depreciation Amortization | 4,145 | 3,103 | 2,066 | 1,032 | 4,903 |
| Accounts receivable | -5,243 | 1,271 | 1,385 | 1,214 | -1,943 |
| Other Working Capital | 2,163 | 2,193 | 1,385 | 1,128 | 1,293 |
| Other Operating Activity | 6,732 | -202 | -606 | -723 | 1,579 |
| Operating Cash Flow | $4,933 | $4,930 | $4,742 | $3,899 | $-612 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -98 | -98 | -74 | -48 | -67 |
| Purchase Of Investment | -2,477 | -1,448 | -836 | -1,162 | N/A |
| Purchase Sale Intangibles | -84 | -41 | -32 | -18 | -113 |
| Other Investing Activity | -2,131 | -88 | -32 | -18 | 124 |
| Investing Cash Flow | $-4,707 | $-1,633 | $-942 | $-1,228 | $58 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 0 | 38,489 |
| Debt Repayment | -10,035 | -10,035 | -10,035 | -10,035 | -35,997 |
| Common Stock Issued | 5,266 | 5,266 | 5,266 | 5,266 | N/A |
| Common Stock Repurchased | -264 | -264 | -253 | -246 | -579 |
| Other Financing Activity | -1,713 | -1,031 | -655 | -511 | -1,716 |
| Financing Cash Flow | $-6,746 | $-6,064 | $-5,677 | $-5,526 | $197 |
| Beginning Cash Position | 17,964 | 17,964 | 17,964 | 17,964 | 18,322 |
| End Cash Position | 11,445 | 15,197 | 16,087 | 15,108 | 17,964 |
| Net Cash Flow | $-6,520 | $-2,767 | $-1,877 | $-2,856 | $-357 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,933 | 4,930 | 4,742 | 3,899 | -612 |
| Capital Expenditure | -98 | -98 | -74 | -48 | -67 |
| Free Cash Flow | 4,835 | 4,832 | 4,668 | 3,851 | -679 |